Acidosis, Lactic Clinical Trial
Official title:
The Effects of Whole Body Periodic Acceleration on Blood Lactate and Recovery in Trained Individuals
Verified date | March 2018 |
Source | New York Institute of Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a
diverse and growing list of disorders including cardiovascular disease 6. During WBPA,
patients lie in the supine position on a bed that is capable of translating back and forth
parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is
best described as a form of "passive exercise." The frequency of the translation (up to 180
cycles/minute; cpm) as well as the distance traveled (2-24mm) by the bed can be adjusted by
the patient or health care professional.
The science behind the therapeutic effects of WBPA still remains largely unknown.
The objective of this study is to determine if WBPA may be used as an effective way to reduce
lactic acid concentrations during recovery after intense exercise more rapidly than
previously established methods.
Status | Completed |
Enrollment | 32 |
Est. completion date | June 1, 2017 |
Est. primary completion date | May 4, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: - Athletic Individuals who exercise regularly Exclusion Criteria: - Any implantable devices - currently taking any medication that would effect blood pressure - pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | New York Institute of Technology | Old Westbury | New York |
Lead Sponsor | Collaborator |
---|---|
New York Institute of Technology |
United States,
Brown J, Glaister M. The interactive effects of recovery mode and duration on subsequent repeated sprint performance. J Strength Cond Res. 2014 Mar;28(3):651-60. doi: 10.1519/JSC.0b013e3182a1fe28. — View Citation
Gmada N, Bouhlel E, Mrizak I, Debabi H, Ben Jabrallah M, Tabka Z, Feki Y, Amri M. Effect of combined active recovery from supramaximal exercise on blood lactate disappearance in trained and untrained man. Int J Sports Med. 2005 Dec;26(10):874-9. — View Citation
Kohler M, Amann-Vesti BR, Clarenbach CF, Brack T, Noll G, Russi EW, Bloch KE. Periodic whole body acceleration: a novel therapy for cardiovascular disease. Vasa. 2007 Nov;36(4):261-6. — View Citation
Sackner MA, Gummels E, Adams JA. Effect of moderate-intensity exercise, whole-body periodic acceleration, and passive cycling on nitric oxide release into circulation. Chest. 2005 Oct;128(4):2794-803. — View Citation
Sackner MA, Gummels E, Adams JA. Nitric oxide is released into circulation with whole-body, periodic acceleration. Chest. 2005 Jan;127(1):30-9. — View Citation
Taoutaou Z, Granier P, Mercier B, Mercier J, Ahmaidi S, Prefaut C. Lactate kinetics during passive and partially active recovery in endurance and sprint athletes. Eur J Appl Physiol Occup Physiol. 1996;73(5):465-70. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood Lactate | We will use a finger stick to collect plasma post exercise | 20 minutes post exercise | |
Secondary | Oxygen Uptake | Oxygen uptake is measured by a subject wearing a mask that measures what they exhale. | 20 minutes post exercsie |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00031161 -
Prevention of Dichloroacetate Toxicity
|
N/A | |
Completed |
NCT01262196 -
Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients
|
Phase 2 | |
Enrolling by invitation |
NCT02699736 -
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
|
||
Completed |
NCT01524315 -
Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery
|
Phase 4 | |
Completed |
NCT01004198 -
Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients
|
Phase 2 | |
Completed |
NCT00143702 -
D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)
|
Phase 2/Phase 3 |